Practical Assessment of an Interdisciplinary Bacteriophage Delivery Pipeline for Personalized Therapy of Gram-Negative Bacterial Infections

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 15; no. 2; p. 186
• Main Authors: Würstle, Silvia, Stender, Jana, Hammerl, Jens André, Vogele, Kilian, Rothe, Kathrin, Willy, Christian, Bugert, Joachim Jakob
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.02.2022; MDPI
• Subjects: Antibiotics; antimicrobial resistance; Bacteria; Bacterial infections; bacteriophage; cell-free extract; Coronaviruses; COVID-19; COVID-19 superinfection; Disease transmission; E coli; Genomes; Good Manufacturing Practice; Gram-negative bacteria; Infections; Interdisciplinary aspects; Klebsiella spp; Laboratories; Patients; phage therapy; Pipelines; Virulence; cell-free extract; in vitro phage production; antimicrobial resistance; phage therapy; bacteriophage; COVID-19 superinfection; Klebsiella spp
• ISSN: 1424-8247; 1424-8247
• DOI: 10.3390/ph15020186

Despite numerous advances in personalized phage therapy, smooth logistics are challenging, particularly for multidrug-resistant Gram-negative bacterial infections requiring high numbers of specific lytic phages. We conducted this study to pave the way for efficient logistics for critically ill patients by (1) closely examining and improving a current pipeline under realistic conditions, (2) offering guidelines for each step, leading to safe and high-quality phage supplies, and (3) providing a tool to evaluate the pipeline's efficiency. Due to varying stipulations for quality and safety in different countries, we focused the pipeline on all steps up to a required phage product by a cell-free extract system. The first of three study runs included patients with respiratory bacterial infections from four intensive care units, and it revealed a cumulative time of up to 23 days. Ultimately, adjustment of specific set points of the vulnerable components of the pipeline, phage isolation, and titration increased the pipeline's efficiency by 15% and decreased the maximum required time to 13 days. We present a site-independent practical approach to establish and optimize pipelines for personalized phage delivery, the co-organization of pipeline components between different institutions, non-binding guidelines for every step, and an efficiency check for phage laboratories.